Clinical trial
A Phase I/II Trial of TPI-287 in Patients With Refractory or Recurrent Neuroblastoma and Medulloblastoma
NCT01483820 is registered in ClinicalTrials.gov with Giselle Sholler as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Trial of TPI-287 in Patients With Refractory or Recurrent Neuroblastoma and Medulloblastoma
- Lead sponsor
- Giselle Sholler
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- December 31, 2011
- Completion date
- December 31, 2014
- Enrollment
- 8 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.